Letter in response to: “Randomised open label exploratory, safety and tolerability study with calmangafodipir in patients treated with the 12-h regimen of N acetylcysteine for paracetamol overdose—the PP100-01 for Overdose of Paracetamol (POP) trial: study protocol for a randomised controlled trial”

Guardado en:
Detalles Bibliográficos
Publicado en:Trials
Autores principales: Karlsson, Jan Olof G., Jynge, Per, Lundström, Ingemar, Ignarro, Louis J.
Formato: Artigo
Lenguaje:Inglês
Publicado: BioMed Central 2019
Materias:
Letter
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6591909/
https://ncbi.nlm.nih.gov/pubmed/31234946
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-019-3476-3
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares